Gustave Roussy célèbre la recherche clinique lors d’une semaine dédiée

Nanomedicine laboratory - lab members

Alexandre, DETAPPE, team leader
Valeriya, DIMITROVA, lab manager

Nanomedicine laboratory - publications

back to job offer list

back to clinical trials

Nanomedicine laboratory - major publications

Durand A, Gréa T, Lebeau G, Jacquot G, Tillement A, Aigle A, Thomas E, Kryza D, Taleb J, Ferrauto G, Gianolio E, Géloen A, Montembault A, Guttierez-Blanco M, Pivot X, Harlepp S, Detappe A, David L†, Lux F†, Tillement O^†. “Functionalization of chitosan with polycarboxylic macrocycle yields injectable hydrogel with pH and salts responsiveness”. Mater Today Adv, 2025.

Nanomedicine laboratory

back to job offer list

back to clinical trials

Nanomedicine laboratory - Presentation

This team belongs to the UMR 1030 Molecular Radiotherapy and Novel Therapeutics

Our team develops new ways to diagnose and treat cancer using tiny, smart particles called nanomedicines. By combining advanced imaging and targeted therapies, we aim to detect tumors earlier and make treatments more effective and safer. Our ultimate goal is to bring these innovations quickly from the lab to the clinic, so they can directly benefit patients.

05/07/2025

Gustave Roussy célèbre la recherche clinique lors d’une semaine dédiée

Organisée pour sa cinquième édition du 19 au 25 mai, la Semaine de la Recherche Clinique de Gustave Roussy met cette année en lumière la radiologie interventionnelle, une spécialité médicale dite mini-invasive qui permet de détruire à l’aiguille des tumeurs ou des métastases, mais également de réaliser des biopsies.

Genome dynamics and instability - Publications

back to job offer list

back to clinical trials

Genome dynamics and instability: major publications

Genome dynamics and instability

back to job offer list

back to clinical trials

Genome dynamics and instability

This team belongs to the UMR 9019 Genome Integrity and Cancers.

Research topics

Genome dynamics and stability

The Genome dynamics and stability team aims to understand how alterations in genome metabolism and stability impact tumorigenesis, cancer progression, treatment choice, and aging.